VOR

Conviction 82HealthcareScan · Thu, Sep 24, 2026

Vor Biopharma Inc. (VOR) closed at $18.44 (-4.80%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 31, RS Rating 46, -62.2% from its 52-week high, +58.4% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

VOR$18.44-4.80%

ResistanceSupportVol 14Insider sell

Vol MA14 1.58M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Vor Biopharma Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.vorbio.com ↗

Price18.44

Change-4.80%

Gap-0.88%

Rel volume2.48×

Avg volume1.3M

Avg $ vol28.25M

SMA 2022.53

SMA 5021.98

SMA 20016.55

Price vs 50-16.10%

Price vs 200+11.45%

MA stackmixed

50/200 cross—

Supertrenddown · 22.85

RSI (14)31

MACD hist-0.55

MACD cross—

Stoch %K / %D9 / 11

ADX (14)18

+DI / −DI22 / 33

RSI divergence—

MACD divergence—

ATR %7.64%

ADR %5.81%

52w high48.72

52w low6.86

From 52w high-62.15%

Above 52w low+168.80%

New 52w highNo

SqueezeOff

Bollinger width28.69%

%B-0.13

Donchian pos9.46%

Donchian high26.00

Donchian low17.65

AVWAP (52w high)15.88

vs AVWAP high+16.11%

AVWAP (52w low)15.43

vs AVWAP low+19.48%

OBV trendDown

Chaikin MF (20)-0.33

Today vs 20d2.48×

Avg vol (14d)1.58M

Avg vol (20d)1.3M

Avg $ vol (20d)28.25M

Market cap1.09B

RS Rating46 / 99

RS 3m (vs SPY)+19.02%

RS 6m (vs SPY)+25.69%

RS line new highNo

Trend template6/8

Technical rank56.2

1 week-15.76%

1 month-23.20%

3 months+23.51%

6 months+42.50%

1 year-41.05%

YTD+58.42%

P/E-1.57

P/B-5.45

P/S—

P/FCF-7.59

EPS-70.50

Div yield—

ROE347.65%

ROA-144.68%

Debt/Eq—

Current19.15

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-495.29%

Price target37.20

Target upside101.74%

Analyst ratingBuy

Institutional83.25%

Ent. value983.1M

Revenue—

Net income-62.81M

Gross profit—

Free cash flow-143.65M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out54.19M

Employees76

ListedFri, Feb 5, 2021

Free float29.19M

Float %70.3%

Short interest7.67M

Days to cover10.4d

Short volume50.8%

Squeeze score87 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.80 vs −$0.69

Last surprise-15.9% miss

Setup gradeA

Conviction82 / 100

Pattern quality—

Tech rank56.2 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance25.27

Support21.49

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Aug 17 – Aug 19
3 scans
→
Breaking out now
Sep 2
1 scan

Congress activity

Disclosed STOCK Act trades in VOR

All disclosures →

No recent disclosed trades by Congress in VOR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VOR · open-market 7 sells

Insider	Side	Shares	Value	Traded	Filed
RA CAPITAL MANAGEMENT, L.P. 10% owner · Stock Option (Right to Buy) · 2026-08-24	Exercise	1.5K	—	2026-08-24	2026-08-26
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-08-24	Exercise	1.5K	$6K	2026-08-24	2026-08-26
ZACCARDELLI DAVID Director · Stock Option (Right to Buy) · 2026-07-07	Grant	42.66K	—	2026-07-07	2026-07-09
Kolchinsky Peter Director · Common Stock · 2026-04-22	Sell	165.15K	$2.6M	2026-04-22	2026-04-24
RA Capital Healthcare Fund LP Director · Common Stock · 2026-04-22	Sell	165.15K	$2.6M	2026-04-22	2026-04-24
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-04-22	Sell	165.15K	$2.6M	2026-04-22	2026-04-24
Shah Rajeev M. Director · Common Stock · 2026-04-22	Sell	165.15K	$2.6M	2026-04-22	2026-04-24
Shah Rajeev M. Director · Common Stock · 2026-04-20	Sell	171.96K	$2.7M	2026-04-20	2026-04-21
Kolchinsky Peter Director · Common Stock · 2026-04-20	Sell	171.96K	$2.7M	2026-04-20	2026-04-21
RA Capital Healthcare Fund LP Director · Common Stock · 2026-04-20	Sell	171.96K	$2.7M	2026-04-20	2026-04-21

SEC filings

EDGAR filings in VOR · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.